Seminars in Nuclear Medicine
Volume 36, Issue 3 , Pages 185-193 , July 2006

Benign Thyroid Disease: What Is the Role of Nuclear Medicine?

  • Salil D. Sarkar, MD, FACP

      Affiliations

    • Nuclear Medicine, Jacobi Medical Center, North Bronx Health Network, Bronx, NY
    • Albert Einstein College of Medicine of Yeshiva University, Bronx, NY.
    • Corresponding Author InformationAddress reprint requests to Salil D. Sarkar, MD, FACP, Jacobi Medical Center, Department of Nuclear Medicine, BN-13, Pelham Pkwy and Eastchester Road, Bronx, NY 10461

References 

  1. Sawin CT , Becker DV . Radioiodine and the treatment of hyperthyroidism (the early history) . Thyroid . 1997;7:163–176
  2. Pierce EN , Farwell AP , Braverman LE . Thyroiditis . N Engl J Med . 2003;348:2646–2655
  3. Stagnaro-Green A . Postpartum thyroiditis . J Clin Endocrinol Metab . 2002;87:4042–4047
  4. Freitas J , Gross MD , Sarkar SD . Laboratory (in vitro) assessment of thyroid function . In:  Sandler MP , et al. editor. Diagnostic Nuclear Medicine . (ed 4). Philadelphia, PA: Lippincott Williams and Wilkins; 2003;p. 591–606
  5. Alexander EK , Larsen PR . High dose of 131I therapy for the treatment of hyperthyroidism caused by Graves’ disease . J Clin Endocrinol Metab . 2002;87:1073–1077
  6. Hiraiwa T , Ito M , Imagawa A , et al.   High diagnostic value of a radioiodine uptake test with and without iodine restriction in Graves’ disease and silent thyroiditis . Thyroid . 2004;14:531–535
  7. Sarkar SD , Becker DV . Thyroid uptake and imaging . In:  Becker KL editors. Principles and Practice of Endocrinology and Metabolism . (ed 3). Philadelphia, PA: Lippincott Williams and Wilkins; 2001;p. 336–342
  8. Carella C , Mazziotti G , Amato G , et al.   IFN α-related thyroid disease (epidemiological, pathophysiological, and clinical aspects) . J Clin Endocrinol Metab . 2004;88:3656–3661
  9. Vialletes B , Guillerand MA , Viens P , et al.   Incidence rate and risk factors for thyroid dysfunction during recombinant interleukin-2 therapy in advanced malignancies . Acta Endocrinol . 1993;129:31–38
  10. Jimenez C , Moran SA , Sereti I , et al.   Graves’ disease after interleukin-2 therapy in a patient with human immunodeficiency virus infection . Thyroid . 2004;14:1097–1102
  11. Miller KK , Daniels GH . Association between lithium use and thyrotoxicosis caused by silent thyroiditis . Clin Endocrinol . 2001;55:501–508
  12. Daniels GH . Amiodarone-induced thyrotoxicosis . J Clin Endocrinol Metab . 2001;86:3–8
  13. Basaria S , Cooper DS . Amiodarone and the thyroid . Am J Med . 2005;118:706–714
  14. Premawardhana LDKE , Parkes AB , John R , et al.   Thyroid peroxidase antibodies in early pregnancy (utility for prediction of postpartum thyroid dysfunction and implications for screening) . Thyroid . 2004;14:610–615
  15. Fradkin JE , Wolff J . Iodide-induced thyrotoxicosis . Medicine . 1983;62:1–20
  16. Fountoulakis S , Tsatsoulis A . On the pathogenesis of autoimmune thyroid disease (a unifying hypothesis) . Clin Endocrinol . 2004;60:397–409
  17. Weetman AP . Graves’ disease . N Engl J Med . 2000;343:1236–1248
  18. Kahaly GJ , Dillmann WH . Thyroid hormone action in the heart . Endocr Rev . 2005;26:704–728
  19. Klein I , Ojamaa K . Thyroid hormone and the cardiovascular system . N Engl J Med . 2001;344:501–509
  20. Burch HB , Wartofsky L . Graves’ ophthalmopathy (Current concepts regarding pathogenesis and management) . Endocr Rev . 1993;14:747–785
  21. Krohn K , Fuhrer D , Bayer Y , et al.   Molecular pathogenesis of euthyroid and toxic multinodular goiter . Endocr Rev . 2005;26:504–524
  22. Sarkar SD . The thyroid gland . In:  Elgazzar A editors. The Pathologic Basis of Nuclear Medicine . Heidelberg: Springer-Verlag; 2001;
  23. Cooper DS . Antithyroid drugs . N Engl J Med . 2005;352:905–917
  24. McDermott MT , Kidd GS , Dodson LE , et al.   Radioiodine-induced thyroid storm (case report and literature review) . Am J Med . 1983;75:353–359
  25. Bartalena L , Marcocci C , Bogazzi F , et al.   Relation between therapy for hyperthyroidism and the course of Graves’ ophthalmopathy . N Eng J Med . 1998;338:73–78
  26. Perros P , Kendall-Taylor P , Neoh C , et al.   Aprospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active Graves’ ophthalmopathy . J Clin Endocrinol Metab . 2005;90:5321–5323
  27. Burch HB , Solomon BL , Cooper DS , et al.   The effect of antithyroid drug treatment on acute changes in thyroid hormone levels after 131I ablation for Graves’ disease . J Clin Endocrinol Metab . 2001;86:3016–3021
  28. Kadmon PM , Noto RB , Boney CM , et al.   Thyroid storm in a child following radioactive iodine (RAI) therapy (a consequence of RAI versus withdrawal of antithyroid medication) . J Clin Endocrinol Metab . 2001;86:1865–1867
  29. Bogazzi F , Bartalena L , Campomori A , et al.   Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves’ disease . J Clin Endocrinol Metab . 2002;87:4490–4495
  30. Kita T , Yokoyama K , Kinuya S , et al.   Single dose planning for radioiodine-131 therapy of Graves’ disease . Ann Nucl Med . 2004;18:151–155
  31. Reinhardt MJ , Brink I , Joe AY , et al.   Radioiodine therapy in Graves’ disease based on tissue-absorbed dose calculations (effect of pre-treatment thyroid volume on final outcome) . Eur J Nucl Med Mol Imaging . 2002;29:1118–1124
  32. Rivkees S . Radioactive iodine use in childhood Graves’ disease (time to wake up and smell the I-131) . J Clin Endocrinol Metab . 2004;89:4227–4228
  33. Braga M , Walpert N , Burch HB , et al.   The effect of methimazole on cure rates after radioiodine treatment for Graves’ hyperthyroidism (a randomized clinical trial) . Thyroid . 2002;12:135–139
  34. Parle JV , Maisonneuve P , Sheppard MC , et al.   Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result (a 10-year cohort study) . Lancet . 2001;358:861–865
  35. Biondi B , Palmieri EA , Fazio S , et al.   Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients . J Clin Endocrinol Metab . 2000;85:4701–4705
  36. Sgarbi JA , Villaca FG , Garbeline B , et al.   The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities . J Clin Endocrinol Metab . 2003;88:1672–1677
  37. Surks MI , Ortiz E , Daniels GH , et al.   Subclinical thyroid disease (scientific review and guidelines for diagnosis and management) . JAMA . 2004;291:228–238
  38. Imaizumi M , Akahoshi M , Ichimaru S , et al.   Risk of ischemic heart disease and all-cause mortality in subclinical hypothyroidism . J Clin Endocrinol Metab . 2004;89:3365–3370
  39. Kvetny J , Heldgaard PE , Bladbjerg EM , et al.   Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years . Clin Endocrinol . 2004;61:232–238
  40. Hak AE , Pols HAP , Visser TJ , et al.   Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women . Ann Intern Med . 2000;132:270–2783
  41. Franklyn JA , Sheppard MC , Maisonneuve P . Thyroid function and mortality in patients treated for hyperthyroidism . JAMA . 2005;294:71–80
  42. Ceccarelli C , Bencivelli W , Vitti P , et al.   Radioactive iodine therapy often results in hypothyroidism in patients with hyperfunctioning thyroid adenomas . Clin Endocrinol . 2005;62:331–335
  43. Bonnema SJ , Bennedbaek FN , Marving AVJ , et al.   Propylthiouracil before 131I therapy of hyperthyroid disease (effect on cure rate evaluated by a randomized clinical trial) . J Clin Endocrinol Metab . 2004;89:4439–4444
  44. Santos RB , Romaldini JH , Ward LS . Propylthiouracil reduces the effectiveness of radioiodine treatment in hyperthyroid patients with Graves’ disease . Thyroid . 2004;14:525–530
  45. Huysmans DAKC , Hermus ARMM , Corstens FHM , et al.   Large, compressive goiters treated with radioiodine . Ann Intern Med . 1994;121:757–762
  46. Bonnema SJ , Bertelsen H , Mortensen J , et al.   The feasibility of high dose iodine-131 treatment as an alternative to surgery in patients with a very large goiter (effect of thyroid function and size and pulmonary function) . J Clin Endocrinol Metab . 1999;84:3636–3641
  47. Silva MNC , Rubio IGS , Romao R , et al.   Administration of a single dose of recombinant human thyrotropin enhances the efficacy of radioiodine treatment of large compressive multinodular goiters . Clin Endocrinol . 2004;60:300–308
  48. Albino CC , Junior M , Olandoski M , et al.   Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine . J Clin Endocrinol Metab . 2005;90:2775–2780
  49. Stoffer SS , Hamburger JI . Inadvertent I-131 therapy for hyperthyroidism in the first trimester of pregnancy . J Nucl Med . 1975;17:146–149
  50. Nygaard B , Knudsen JH , Hegedus L , et al.   Thyrotropin receptor antibodies and Graves’ disease, a side effect of I-131 treatment in patients with nontoxic goiter . J Clin Endocrinol Metab . 1997;82:2926–2930
  51. Castro MR , Gharib H . Continuing controversies in the management of thyroid nodules . Ann Intern Med . 2005;142:926–931
  52. Sarkar SD . Benign thyroid disease, in Life Long Learning and Self Assessment Program, Endocrinology Module . Reston, VA: Society of Nuclear Medicine; 2006;
  53. Cooper DS , Doherty GM , Haugen BR , et al.   Management guidelines for patients with thyroid nodules and differentiated thyroid cancer . Thyroid . 2006;16:1–33
  54. Baudin E , Travagli JP , Ropers J , et al.   Microcarcinoma of the thyroid gland—the Gustav-Roussy Institute experience . Cancer . 1998;83:553–559
  55. Ito Y , Uruno T , Nakano K , et al.   An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid . Thyroid . 2003;13:381–387
  56. Schneider AB , Ron E . Carcinoma of follicular epithelium (Epidemiology and pathogenesis) . In:  Braverman LE ,  Utiger RD editor. Werner and Ingbar’s Thyroid . (ed 9). Philadelphia, PA: Lippincott Williams and Wilkins; 2005;p. 889–906
  57. Frates MC , Benson CB , Charboneau JW , et al.   Management of thyroid nodules detected at ultrasound (Society of Radiologists in Ultrasound consensus conference statement) . Radiology . 2005;237:794–800
  58. Papini E , Guglielmi R , Bianchini A , et al.   Risk of malignancy in nonpalpable thyroid nodules (predictive value of ultrasound and color Doppler features) . J Clin Endocrinol Metab . 2002;87:1941–1946
  59. Gianoukakis AG , Karam M , Cheema A , et al.   Autonomous thyroid nodules visualized by positron emission tomography with 18F-fluorodeoxyglucose (Case report and review of the literature) . Thyroid . 2003;13:395–399
  60. Mitchell JC , Grant F , Evenson AR , et al.   Preoperative evaluation of thyroid nodules with 18FDG-PET/CT . Surgery . 2005;138:1166–1174
  61. Committee on Genetics and American Thyroid Association Committee on Public Health . Newborn screening for congenital hypothyroidism (Recommended guidelines) . Pediatrics . 1993;91:1203–1209
  62. Schoen EJ , Clapp W , To TT , et al.   The key role of newborn thyroid scintigraphy with isotopic iodide (123I) in defining and managing congenital hypothyroidism . 2004;114:683–688
  63. Glinoer D . Management of hypo- and hyperthyroidism during pregnancy . Growth Horm IGF Res . 2003;13(suppl):S45–S54
  64. Evans C , Jordan NJ , Owens G , et al.   Potent thyrotropin receptor-blocking antibodies (A cause of transient congenital hypothyroidism and delayed thyroid development) . Eur J Endocrinol . 2004;150:265–268
  65. Kempers MJE , van Tijn DA , van Trotsenburg ASP . Central congenital hypothyroidism due to gestational hyperthyroidism (Detection where prevention failed) . J Clin Endocrinol Metab . 2003;88:5851–5857
  66. Roti E , Minelli R , Gardini E , et al.   The iodine perchlorate discharge test before and after one year of methimazole treatment of hyperthyroid Graves’ disease . J Clin Endocrinol Metab . 1994;78:795–799

PII: S0001-2998(06)00020-1

doi: 10.1053/j.semnuclmed.2006.03.006

Seminars in Nuclear Medicine
Volume 36, Issue 3 , Pages 185-193 , July 2006

Article Tools

* Image Usage & Resolution